| Autor: |
Elena Montes-Cobos, Victoria C Bastos, Clarice Monteiro, João CR de Freitas, Heiny DP Fernandes, Clarice S Constancio, Danielle AS Rodrigues, Andreza MDS Gama, Vinicius M Vidal, Leticia S Alves, Laura Zalcberg-Renault, Guilherme S de Lira, Victor A Ota, Carolina Caloba, Luciana Conde, Isabela C Leitão, Amilcar Tanuri, Orlando DC Ferreira, Renata M Pereira, André M Vale, Terezinha M Castiñeiras, Dominique Kaiserlian, Juliana Echevarria-Lima, Marcelo T Bozza |
| Rok vydání: |
2022 |
| DOI: |
10.1101/2022.11.19.22282546 |
| Popis: |
SummaryThe vast spectrum of clinical features of COVID-19 keeps challenging scientists and clinicians. Control of pathogen load (host resistance) and prevention of tissue damage (disease tolerance) are essential for the outcome of infectious diseases. Both low resistance and high disease tolerance might result in long-term viral persistence, but the underlying mechanisms remain unclear. Here, we studied the immune response of immunocompetent COVID-19 patients with prolonged SARS-CoV-2 infection by immunophenotyping, cytokine and serological analysis. Despite viral loads and symptoms comparable to regular mildly-symptomatic patients, long-term carriers displayed weaker systemic IFN-I responses and fewer circulating pDCs and NK cells at disease onset. Type 1 cytokines remained low, while type-3 cytokines were in turn enhanced. Interestingly, the plasma of these patients showed a higher spike-specific neutralization capacity. The identification of very early distinct immune responses in long-term carriers adds up to our understanding on essential host protective mechanisms to ensure tissue damage control despite prolonged viral infection. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
